Drug Type Stem cell therapy |
Synonyms Kyslecel |
Target- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Koligo Therapeutics, Inc.Startup |
Active Organization Koligo Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (22 Aug 2018), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Pancreatitis, Chronic | US | Koligo Therapeutics, Inc.Startup | 22 Aug 2018 |